T helper type (Th1/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses
E Aleebrahim-Dehkordi, B Molavi, M Mokhtari… - Transplant …, 2022 - Elsevier
Cytokines produced by T helper cells (T h cells) have essential roles in the body's defense
against viruses. Type 1 T helper (Th1) cells are essential for the host defense toward …
against viruses. Type 1 T helper (Th1) cells are essential for the host defense toward …
[HTML][HTML] Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
MS Buckland, JB Galloway, CN Fhogartaigh… - Nature …, 2020 - nature.com
The response to the coronavirus disease 2019 (COVID-19) pandemic has been hampered
by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
H Schulze-Koops, K Krueger, I Vallbracht… - Annals of the …, 2021 - ard.bmj.com
It is currently unknown whether immunosuppressive and/or immunomodulating agents such
as biological disease-modifying antirheumatic drugs (bDMARDs) affect the rate and the …
as biological disease-modifying antirheumatic drugs (bDMARDs) affect the rate and the …
[HTML][HTML] Multiple sclerosis disease-modifying therapy and the COVID-19 pandemic: implications on the risk of infection and future vaccination
C Zheng, I Kar, CK Chen, C Sau, S Woodson, A Serra… - CNS drugs, 2020 - Springer
Abstract The coronavirus 2019 (COVID-19) pandemic is expected to linger. Decisions
regarding initiation or continuation of disease-modifying therapy for multiple sclerosis have …
regarding initiation or continuation of disease-modifying therapy for multiple sclerosis have …
Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection
COVID-19 is a global pandemic caused by the SARS-CoV-2 coronavirus. T cells play a key
role in the adaptive antiviral immune response by killing infected cells and facilitating the …
role in the adaptive antiviral immune response by killing infected cells and facilitating the …
[HTML][HTML] Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID-19 en establecimientos de atención de la salud …
CH Saavedra Trujillo - Infectio, 2020 - scielo.org.co
En Colombia la implementación de procesos de detección, prevención y disminu ción de
riesgos en salud y seguridad en el trabajo, es responsabilidad de los prestadores de …
riesgos en salud y seguridad en el trabajo, es responsabilidad de los prestadores de …
[HTML][HTML] SARS-CoV-2 vaccine induced atypical immune responses in antibody defects: everybody does their best
AF Salinas, EP Mortari, S Terreri, C Quintarelli… - Journal of clinical …, 2021 - Springer
Background Data on immune responses to SARS-CoV-2 in patients with Primary Antibody
Deficiencies (PAD) are limited to infected patients and to heterogeneous cohorts after …
Deficiencies (PAD) are limited to infected patients and to heterogeneous cohorts after …
[HTML][HTML] Clinical implications of host genetic variation and susceptibility to severe or critical COVID-19
CI van der Made, MG Netea, FL van der Veerdonk… - Genome Medicine, 2022 - Springer
Since the start of the coronavirus disease 2019 (COVID-19) pandemic, important insights
have been gained into virus biology and the host factors that modulate the human immune …
have been gained into virus biology and the host factors that modulate the human immune …
Treatment of chronic or relapsing COVID-19 in immunodeficiency
LAK Brown, E Moran, A Goodman, H Baxendale… - Journal of Allergy and …, 2022 - Elsevier
Background Patients with some types of immunodeficiency can experience chronic or
relapsing infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …
relapsing infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …
[HTML][HTML] IgA antibodies and IgA deficiency in SARS-CoV-2 infection
I Quinti, EP Mortari, A Fernandez Salinas… - Frontiers in Cellular …, 2021 - frontiersin.org
A large repertoire of IgA is produced by B lymphocytes with T-independent and T-dependent
mechanisms useful in defense against pathogenic microorganisms and to reduce immune …
mechanisms useful in defense against pathogenic microorganisms and to reduce immune …